Equifax (NYSE:EFX) PT Raised to $291.00 at Oppenheimer

Equifax logo with Business Services background

Equifax (NYSE:EFX - Free Report) had its target price lifted by Oppenheimer from $273.00 to $291.00 in a research note released on Tuesday morning, Benzinga reports. They currently have an outperform rating on the credit services provider's stock.

A number of other research analysts have also recently weighed in on the stock. The Goldman Sachs Group raised their price objective on shares of Equifax from $195.00 to $222.00 and gave the stock a neutral rating in a research note on Friday, December 29th. Evercore ISI upgraded Equifax from an in-line rating to an outperform rating and upped their price objective for the company from $210.00 to $310.00 in a research report on Tuesday, February 13th. Wells Fargo & Company upgraded Equifax from an equal weight rating to an overweight rating and lifted their price objective for the stock from $200.00 to $290.00 in a research report on Friday, December 15th. TheStreet raised shares of Equifax from a c+ rating to a b- rating in a research note on Friday, December 29th. Finally, Jefferies Financial Group raised shares of Equifax from a hold rating to a buy rating and boosted their price objective for the company from $200.00 to $315.00 in a research report on Monday, December 18th. Four investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat.com, Equifax presently has a consensus rating of Moderate Buy and an average price target of $267.00.


Read Our Latest Stock Report on EFX

Equifax Price Performance

Shares of EFX stock traded up $3.71 during midday trading on Tuesday, reaching $262.74. 664,132 shares of the company traded hands, compared to its average volume of 769,252. The firm has a market cap of $32.64 billion, a PE ratio of 59.71, a price-to-earnings-growth ratio of 2.02 and a beta of 1.51. The company has a debt-to-equity ratio of 1.04, a current ratio of 0.67 and a quick ratio of 0.67. The firm's 50 day simple moving average is $259.36 and its two-hundred day simple moving average is $228.78. Equifax has a 1-year low of $159.95 and a 1-year high of $275.10.

Equifax (NYSE:EFX - Get Free Report) last issued its quarterly earnings data on Wednesday, February 7th. The credit services provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.07. Equifax had a return on equity of 19.40% and a net margin of 10.36%. The firm had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.31 billion. During the same period in the previous year, the firm posted $1.52 earnings per share. Equifax's revenue was up 10.7% on a year-over-year basis. On average, equities research analysts expect that Equifax will post 7.51 EPS for the current fiscal year.

Equifax Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Friday, February 23rd were issued a $0.39 dividend. The ex-dividend date of this dividend was Thursday, February 22nd. This represents a $1.56 annualized dividend and a yield of 0.59%. Equifax's payout ratio is 35.45%.

Institutional Investors Weigh In On Equifax

Several institutional investors have recently bought and sold shares of EFX. Welch Group LLC acquired a new position in shares of Equifax during the 1st quarter valued at $222,000. Mather Group LLC. purchased a new position in Equifax in the first quarter valued at about $109,000. GAMMA Investing LLC lifted its stake in shares of Equifax by 28.0% during the first quarter. GAMMA Investing LLC now owns 978 shares of the credit services provider's stock worth $262,000 after purchasing an additional 214 shares in the last quarter. CWM LLC boosted its position in shares of Equifax by 4.7% in the first quarter. CWM LLC now owns 1,414 shares of the credit services provider's stock worth $378,000 after buying an additional 64 shares during the period. Finally, Nomura Holdings Inc. purchased a new stake in shares of Equifax in the fourth quarter worth about $917,000. 96.20% of the stock is currently owned by hedge funds and other institutional investors.

About Equifax

(Get Free Report)

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.

Recommended Stories

Analyst Recommendations for Equifax (NYSE:EFX)

Should you invest $1,000 in Equifax right now?

Before you consider Equifax, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Equifax wasn't on the list.

While Equifax currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Featured Articles and Offers

Search Headlines: